N-[5-(cyclopentylmethylsulfanyl)-1,3,4-thiadiazol-2-yl]-1-methyl-6,7-dihydro-4H-pyrano[4,3-c]pyrazole-3-carboxamide

ID: ALA5284277

Max Phase: Preclinical

Molecular Formula: C16H21N5O2S2

Molecular Weight: 379.51

Names and Identifiers

Canonical SMILES:  Cn1nc(C(=O)Nc2nnc(SCC3CCCC3)s2)c2c1CCOC2

Standard InChI:  InChI=1S/C16H21N5O2S2/c1-21-12-6-7-23-8-11(12)13(20-21)14(22)17-15-18-19-16(25-15)24-9-10-4-2-3-5-10/h10H,2-9H2,1H3,(H,17,18,22)

Standard InChI Key:  LKPHHNKWDSPTGZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   -2.2567    0.3824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4598    0.1688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8764    0.7522    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2462   -0.6279    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4493   -0.8414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1339   -0.2581    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.8792   -0.6497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7498   -1.4446    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0697   -1.5688    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5936   -0.2371    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.3082   -0.6497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0226   -0.2371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0225    0.5876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8263    0.8379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2970    0.1845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8052   -0.4828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8400   -0.2008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5852    0.1906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4560    0.9855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6363    1.1096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0392    1.5688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8065   -1.0421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5183   -1.4917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2635   -1.1001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2970   -0.2588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  6  5  1  0
  6  7  1  0
  7  8  2  0
  9  8  1  0
  5  9  2  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 13 12  1  0
 13 14  1  0
 14 15  1  0
 16 15  1  0
 12 16  1  0
 17  1  1  0
 17 18  2  0
 18 19  1  0
 20 19  1  0
  1 20  2  0
 19 21  1  0
 17 22  1  0
 23 22  1  0
 24 23  1  0
 25 24  1  0
 18 25  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5284277

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 379.51

Molecular Weight (Monoisotopic): 379.1137

AlogP: 2.88

#Rotatable Bonds: 5

Polar Surface Area: 81.93

Molecular Species: NEUTRAL

HBA: 8

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.55

CX Basic pKa: ┄

CX LogP: 2.82

CX LogD: 2.61

Aromatic Rings: 2

Heavy Atoms: 25

QED Weighted: 0.64

Np Likeness Score: -2.17

References

1. Dodd CJ, Chronister KS, Rathnayake U, Parr LC, Li K, Chang S, Mi D, Days EL, Bauer JA, Cho HP, Boutaud O, Denton JS, Lindsley CW, Han C..  (2023)  Synthesis and SAR of a novel Kir6.2/SUR1 channel opener scaffold identified by HTS.,  87  [PMID:36966977] [10.1016/j.bmcl.2023.129256]

Source

Source(1):

• Scientific Literature